Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
490 participants
INTERVENTIONAL
2025-06-01
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the context of the BETTER4U project, the present Pilot Study aims to a) evaluate the usability, feasibility and acceptability of the BETTER4U mobile application ("BETTER4U App") and Intervention Platform that will be used to monitor and collect data from participants in the BETTER4ALL personalized intervention (randomized controlled trial; RCT) and b) collect data to evaluate and improve the BETTER4U causal AI models for the prevention of weight gain, before deploying them at large scale, as well as test and identify the optimal ways of delivering the AI-based interventions to the participants. The study will be conducted in seven sites in Cyprus, France, Greece, Poland, Portugal, Spain, and Sweden.
The BETTER4All Pilot Study will be a longitudinal, correlational, observational study, including a total of n=490 participants, equally distributed among the seven sites (i.e. n=70 per site). Specifically, n=60 (± 3-5) "general population" participants (henceforth: "end-users" of the wearables and the BETTER4U App) and n=10 (± 3-5) healthcare or other types of providers (henceforth: potential "implementers" of the BETTER4U intervention) will constitute each site's sample.
The study will involve the following two components: a) the administration of the wearables (smartwatches) to the "end-users" and their registration to and training on the BETTER4U App, to be used for a total duration of three weeks (21 days). During this period, their lifestyle behaviours (i.e. "BETTER4U Core Behavioural Indicators - BCBIs", such as eating occasions, physical activity, sedentary time, sleep etc.) and "living environment indicators - LEIs"; (e.g. access to parks in your area, distance from your home to your work place etc.) will be recorded daily, either in an automated way via the wearables or self-reported by the end-users through the App; and b) the registration to and training on the BETTER4U Intervention Platform of the "implementers" for a total duration of one week (7 days), during which they will be asked to test the platform's functionalities using synthetic data. The implementers will also be provided with the wearables and the App (similarly to the end-users) for one week only to allow collection of additional data that will help verify the accuracy of the algorithms in the gathered data from the wearables/monitoring tools regarding BCBIs and LEIs.
Overall, the outcomes and the findings of the Pilot Study will be used to further refine, optimize, and adjust the tools for the BETTER4ALL RCT, according to the feedback received by both end-users' and implementers' perspectives.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Better4All Personalized Intervention
NCT06997510
HealthyW8_60+ Pilot
NCT06816147
Empowering Healthy Lifestyle Behavior to Prevent and Control Obesity in Young Adults
NCT06943651
BfedBwell Proof-of-Concept Pilot
NCT06191666
"Program "Cerdanya on Fitness" to Improve the Lifestyle of People With Obesity in Cerdanya (CF).
NCT05420116
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The BETTER4U system employs Bluetooth Low Energy (BLE) smartwatches for passive data collection, including accelerometer signals, heart rate variability, sleep structure, and geolocation data. Data from the wearables and smartphone sensors are processed using AI and machine learning algorithms to derive behavioral indicators such as physical activity, eating, sleep patterns (termed BETTER4U Core Behavioral Indicators - BCBIs), and contextual environmental factors (Living Environment Indicators - LEIs). These indicators are calculated both locally and on secure servers via structured data pipelines, ensuring privacy and GDPR compliance.
Data collection comprises three sources: (1) passively collected wearable/App data, (2) online questionnaires via RedCap (e.g., IPAQ, GAD-2, PHQ-2, EQ-5D-5L, PSQI, Mini-EAT), and (3) "ground truth" data logged by implementers to validate algorithmic outputs. Engagement metrics, such as app usage duration and feature interaction frequency, are also automatically recorded. Feedback on usability and feasibility is collected via validated tools, including the System Usability Scale (SUS), MAUQ, AIM, IAM, and FIM.
The primary technical aim is to verify and refine the causal AI models developed in earlier project phases (WP5), ensuring the system is optimized for personalized intervention delivery in the upcoming BETTER4ALL randomized controlled trial (WP7).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
End-users - General Population Participants
Adults from the general population (aged 18- 65 years, with normal weight or overweight/obesity) who will use the BETTER4U mobile application and a wearable smartwatch for 21 days. During this period, lifestyle behaviors and living environment indicators will be recorded daily, either automatically via the wearable or through self-reports via the app.
BETTER4U Mobile App and Wearable Use (End-User Group)
Participants from the general population ("end-users") will use a smartwatch and the BETTER4U mobile app for 21 days. The app passively collects data (physical activity, sleep, eating behaviors, environment), while participants may self-report certain behaviors. The goal is to assess the usability, feasibility, and acceptability of the tools and to collect real-world behavioral data for refining AI models.
Implementers - Healthcare Professionals
Healthcare professionals (e.g., medical doctors, dietitians/nutritionists, psychologists, nurses) who will use the BETTER4U Intervention Platform, mobile application, and wearable smartwatch for 7 days. During this period, they will interact daily with the Intervention Platform using synthetic data to evaluate its functionalities and usability. Additionally, they will wear the smartwatch and use the app to record lifestyle behavior and living environment indicators (LEIs). They will provide structured "growth truth" data (e.g., transportation mode, activity levels, sleep quality) to validate the accuracy of the AI algorithms. Their feedback will help optimize their intervention delivery system and AI-based tools before large-scale deployment.
BETTER4U Intervention Platform Testing (Implementer Group)
Healthcare professionals and other potential implementers will test the BETTER4U Intervention Platform and mobile app for 7 days. They will assess system usability, complete synthetic case simulations, and provide daily feedback via Google Forms. They also wear the smartwatch and use the app for data validation purposes. The goal is to evaluate platform usability and collect ground-truth data for validating AI algorithm outputs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BETTER4U Mobile App and Wearable Use (End-User Group)
Participants from the general population ("end-users") will use a smartwatch and the BETTER4U mobile app for 21 days. The app passively collects data (physical activity, sleep, eating behaviors, environment), while participants may self-report certain behaviors. The goal is to assess the usability, feasibility, and acceptability of the tools and to collect real-world behavioral data for refining AI models.
BETTER4U Intervention Platform Testing (Implementer Group)
Healthcare professionals and other potential implementers will test the BETTER4U Intervention Platform and mobile app for 7 days. They will assess system usability, complete synthetic case simulations, and provide daily feedback via Google Forms. They also wear the smartwatch and use the app for data validation purposes. The goal is to evaluate platform usability and collect ground-truth data for validating AI algorithm outputs.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index (BMI):
* Overweight or obesity group: BMI ≥ 25 kg/m².
* Normal weight group: BMI 18.5-24.9 kg/m².
* Technology Use:
* Willingness and ability to use wearable devices and an Android mobile application for the duration of the study.
* Owning a smartphone device with the Android operating system.
* Eating utensil technique: dominant hand gestures that correspond to handling of food via a fork or a spoon.
* Language Proficiency: Ability to read and understand the language in which the mobile app and study materials are provided.
* Consent: Willing to provide informed consent to participate in the study.
* Residency: Must be a resident of one of the seven participating countries.
* Availability: Able to participate for the full three-week duration of the study and comply with the study protocol.
Exclusion Criteria
* Physical Limitations: Any physical or mental condition that would prevent the participant from using the wearable device or mobile application as intended.
* Eating utensil technique: eating food with chopsticks on a daily or regular basis.
* Technical Incompatibility: Individuals who do not own a compatible smartphone or are unable to use the provided wearable devices for technical reasons.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Navarra
OTHER
University of Cyprus
OTHER
Karolinska Institutet
OTHER
University SWPS
OTHER
UNIVERSITE LYON 1 CLAUDE BERNARD (UCBL)
UNKNOWN
CENTRO DE ESTUDOS E INVESTIGACAO EM DINAMICAS SOCIAIS E SAUDE ASSOCIACAO SEM FINS LUCRATIVOS (CEIDSS)
UNKNOWN
Harokopio University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yannis Manios
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yannis Manios, Professor
Role: PRINCIPAL_INVESTIGATOR
Department of Nutrition and Dietetics, School of Health Science & Education, Harokopio University, Athens, Greece
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cyprus (Ucy)
Nicosia, , Cyprus
Universite Lyon 1 Claude Bernard (Ucbl)
Villeurbanne, , France
Harokopio University
Athens, Aticca, Greece
Uniwersytet Swps (Swps)
Wroclaw, , Poland
Centro de Estudos E Investigacao Em Dinamicas Sociais E Saude Associacao Sem Fins Lucrativos (Ceidss)
Lisbon, , Portugal
Universidad de Navarra (Unav)
Pamplona, Navarre, Spain
Karolinska Institutet
Huddinge, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Constantinos Deltas, Professor
Role: primary
Julie-Anne Nazare
Role: primary
Aleksandra L, Professor
Role: primary
Ana Isabel Rito, Professor
Role: primary
Mai Bes-Rastrollo, Professor
Role: primary
Ioannis Ioakeimidis
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Better4U website link
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B4U101080117
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.